New eye dye could make retinal scans safer
NCT ID NCT04008121
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 20 times
Summary
This early study tests a new dye called MB-102 for eye imaging (angiography) in 10 people with or without retinal diseases like diabetic retinopathy or macular degeneration. The goal is to see if MB-102 is safe and produces clear images compared to the standard dye, fluorescein sodium. If successful, it could offer a safer alternative for diagnosing eye conditions.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETINOPATHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Michigan Kellogg Eye Center
RECRUITINGAnn Arbor, Michigan, 48105, United States
Contact
Conditions
Explore the condition pages connected to this study.